The drug is called NU-9, and a team from Northwestern University in the US tested it on mouse models of Alzheimer's disease.

The study found that consistent use of certain widely-prescribed medications for bladder disorders, Parkinson's disease, and ...

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and dementia prevention, offering fresh hope in the fight against cognitive ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their brains.

Weight-loss drugs like Ozempic and Mounjaro are so prevalent that 1 in 5 adults in the United States report taking these drugs for obesity. This class of drugs, known as glucagon-like peptide-1 ...

A study found regular use of strong anticholinergic drugs used for bladder conditions, Parkinson's disease and depression ...